Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Levetiracetam Tablets, 1000 mg.
External Link Source » http://www.topix.com
External Link Source » http://www.topix.com
HealthCareInternational.Net?
HealthCare International is a social health care related news, articles & blog aggregation system.
Most Popular Published
Explore Health Care Intl.
Latest Comments
Last 10 Users










Comments